Merantix

Graph Therapeutics is a biotechnology company specializing in precision immunology. It uses artificial intelligence and multi-omics data derived from primary patient cell samples to understand and treat immune-driven diseases. By modeling perturbations in these samples, Graph aims to deliver targeted therapies and biomarkers, addressing the unmet needs of patients with complex immune-mediated diseases.

Briink is a technology company that utilizes artificial intelligence to enhance the workflows of sustainable finance teams. It has developed a platform that automates the environmental, social, and governance (ESG) audit reporting processes for asset managers, auditors, and corporations. By streamlining taxonomy management and facilitating compliance with sustainable finance disclosures, Briink empowers private equity firms and other organizations to make informed investment decisions. The platform aims to improve sustainability profiles, enhance transparency in ESG data, and address issues related to greenwashing, ultimately supporting the broader goals of sustainable finance.

Graph Therapeutics is a biotechnology company specializing in precision immunology. It uses artificial intelligence and multi-omics data derived from primary patient cell samples to understand and treat immune-driven diseases. By modeling perturbations in these samples, Graph aims to deliver targeted therapies and biomarkers, addressing the unmet needs of patients with complex immune-mediated diseases.

Cambrium is a company focused on advancing material innovation by utilizing nature's protein building blocks. It employs a platform that integrates synthetic biology, machine learning, and lab automation to produce high-performance materials at scale. Cambrium specializes in developing micro-molecular and skin-identical collagen specifically tailored for effective skincare formulations. Its proprietary molecular design technology allows for the creation of novel material building blocks from proteins, offering unique functionalities that enhance product efficacy. The company's approach aims to align economic and environmental incentives, positioning biology as a pivotal manufacturing technology for the 21st century. Cambrium seeks to drive a significant transformation in biomaterials to tackle some of the world's most urgent challenges.

Ovom Care is an AI-driven healthcare company that focuses on reproductive care services. It offers a range of personalized fertility solutions, including fertility assessments, preservation, treatments, donor services, and egg freezing, also known as oocyte cryopreservation. Additionally, Ovom Care provides in vitro fertilization (IVF) services, helping patients navigate their fertility journeys with informed decision-making. Through its innovative approach, the company aims to enhance the reproductive health experience for individuals seeking assistance with fertility.

Deltia is a developer of an AI-based process analytics platform that enhances productivity and quality in manual assembly processes. The company utilizes computer vision technology to capture real-time video streams at assembly stations, allowing for continuous analysis of workpiece movements, cycle times, and work step sequencing. This data aggregation enables factory managers and process engineers to gain insights into process performance and conduct comprehensive root-cause analyses. By identifying areas for improvement, Deltia's platform empowers users to define, implement, and measure process enhancements, ultimately reducing errors and increasing efficiency in production environments.

Make your Legal work effortlessly efficient. Our LLM delivers unprecedented legal accuracy while removing the complexity of AI prompting and automation. Our AI workflows chain autonomous AI agents together to automate entire processes, just like in a law firm with specialised teams.

We build AI coaches that hyper-personalize mental health, starting with adult ADHD

Ovom Care is an AI-driven healthcare company that focuses on reproductive care services. It offers a range of personalized fertility solutions, including fertility assessments, preservation, treatments, donor services, and egg freezing, also known as oocyte cryopreservation. Additionally, Ovom Care provides in vitro fertilization (IVF) services, helping patients navigate their fertility journeys with informed decision-making. Through its innovative approach, the company aims to enhance the reproductive health experience for individuals seeking assistance with fertility.

Deltia is a developer of an AI-based process analytics platform that enhances productivity and quality in manual assembly processes. The company utilizes computer vision technology to capture real-time video streams at assembly stations, allowing for continuous analysis of workpiece movements, cycle times, and work step sequencing. This data aggregation enables factory managers and process engineers to gain insights into process performance and conduct comprehensive root-cause analyses. By identifying areas for improvement, Deltia's platform empowers users to define, implement, and measure process enhancements, ultimately reducing errors and increasing efficiency in production environments.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Looks is a mobile application that enables users to customize outfits based on the occasion. Looks was founded in 2022 and was headquartered in Berlin, Germany.

Briink is a technology company that utilizes artificial intelligence to enhance the workflows of sustainable finance teams. It has developed a platform that automates the environmental, social, and governance (ESG) audit reporting processes for asset managers, auditors, and corporations. By streamlining taxonomy management and facilitating compliance with sustainable finance disclosures, Briink empowers private equity firms and other organizations to make informed investment decisions. The platform aims to improve sustainability profiles, enhance transparency in ESG data, and address issues related to greenwashing, ultimately supporting the broader goals of sustainable finance.

Cambrium is a company focused on advancing material innovation by utilizing nature's protein building blocks. It employs a platform that integrates synthetic biology, machine learning, and lab automation to produce high-performance materials at scale. Cambrium specializes in developing micro-molecular and skin-identical collagen specifically tailored for effective skincare formulations. Its proprietary molecular design technology allows for the creation of novel material building blocks from proteins, offering unique functionalities that enhance product efficacy. The company's approach aims to align economic and environmental incentives, positioning biology as a pivotal manufacturing technology for the 21st century. Cambrium seeks to drive a significant transformation in biomaterials to tackle some of the world's most urgent challenges.

Kausa is a company that specializes in data analysis, offering solutions tailored to industries such as media and entertainment, gaming, marketplaces, and e-commerce. It has developed an analytics platform that assists businesses in making data-driven decisions by testing various hypotheses and providing accurate explanations for fluctuations in performance metrics. This enables organizations to understand the reasons behind changes in their key performance indicators (KPIs) and take informed actions to enhance their overall performance. Kausa's services aim to facilitate a deeper understanding of data dynamics within organizations.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Driven by digitalisation, ADAS and automated driving, automotive companies face one of their biggest challenges yet: the amount of data they are collecting is exploding. Most organisations use less than 5% of what they collect, are not able not commercialise their most valuable asset and instead waste millions on excess storage. To address this challenge, we have developed SiaSearch the category-leading search engine for petabyte-scale automotive data. Our technology automatically structures raw sensor data based on semantic attributes and keywords such as cut-ins, crowded intersections or dangerous overtaking. This metadata is powerful. By searching it, we can eliminate the time wasted on manual data crawling, automate the decision of what data to store and provide intelligent suggestions of what data would be most valuable to collect. With SiaSearch we are helping our customers to build smaller, higher density data sets. This does not just fast track their development but enables them to commercialise their data as an asset.

Merantix Momentum is a technology company that specializes in artificial intelligence (AI) services. It employs a team of skilled machine learning engineers, problem solvers, and creative thinkers who work together to help businesses across various industries leverage their potential through AI. The company offers a comprehensive AI strategy, tailored AI services, and reliable AI operations, designed to deliver long-term impact. They focus on machine learning, deep learning, and computer vision, translating their leading AI research into customized services that create domain-specific value.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.